Sunlenca 61958-3001
Generic: Lenacapavir Sodium
Product NDC
61958-3001- Manufacturer
- Gilead Sciences, Inc.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- December 22, 2022
- Listing Expires
- December 31, 2027
- Application
- NDA215974
Need to source Sunlenca? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lenacapavir Sodium | 300 mg/1 |
Drug Class
Breast Cancer Resistance Protein Inhibitors [MoA]Cytochrome P450 3A Inhibitors [MoA]HIV Capsid Inhibitors [MoA]
Packaging Options(3)
1 POUCH in 1 CARTON (61958-3001-1) / 1 BLISTER PACK in 1 POUCH / 4 TABLET, FILM COATED in 1 BLISTER PACK
1 POUCH in 1 CARTON (61958-3001-2) / 1 BLISTER PACK in 1 POUCH / 5 TABLET, FILM COATED in 1 BLISTER PACK
4 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-3001-3)